WO2005018653A1 - スキンケア用の内服組成物 - Google Patents
スキンケア用の内服組成物 Download PDFInfo
- Publication number
- WO2005018653A1 WO2005018653A1 PCT/JP2004/012183 JP2004012183W WO2005018653A1 WO 2005018653 A1 WO2005018653 A1 WO 2005018653A1 JP 2004012183 W JP2004012183 W JP 2004012183W WO 2005018653 A1 WO2005018653 A1 WO 2005018653A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kefir
- composition according
- lactobacillus
- fermented milk
- internal use
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 235000015141 kefir Nutrition 0.000 claims abstract description 83
- 235000015140 cultured milk Nutrition 0.000 claims abstract description 32
- 241000233866 Fungi Species 0.000 claims abstract description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 42
- 241000894006 Bacteria Species 0.000 claims description 41
- 235000013322 soy milk Nutrition 0.000 claims description 34
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 29
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 28
- 239000004310 lactic acid Substances 0.000 claims description 21
- 235000014655 lactic acid Nutrition 0.000 claims description 21
- 239000002054 inoculum Substances 0.000 claims description 19
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 241000186660 Lactobacillus Species 0.000 claims description 13
- 229940039696 lactobacillus Drugs 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- 241000235070 Saccharomyces Species 0.000 claims description 7
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims description 5
- 240000001929 Lactobacillus brevis Species 0.000 claims description 5
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 241000108055 Lactobacillus kefiranofaciens Species 0.000 claims description 4
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 4
- 235000018368 Saccharomyces fragilis Nutrition 0.000 claims description 4
- 244000057717 Streptococcus lactis Species 0.000 claims description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229940031154 kluyveromyces marxianus Drugs 0.000 claims description 4
- 239000006356 lactobacillus kefiranofaciens Substances 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241001468191 Lactobacillus kefiri Species 0.000 claims description 3
- 244000172809 Leuconostoc cremoris Species 0.000 claims description 3
- 235000017632 Leuconostoc cremoris Nutrition 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- SERLAGPUMNYUCK-URHLDCCQSA-N (2R,3S,4R,5S)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol Chemical group OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-URHLDCCQSA-N 0.000 claims description 2
- 241001522017 Brettanomyces anomalus Species 0.000 claims description 2
- 241000194032 Enterococcus faecalis Species 0.000 claims description 2
- 229920001755 Kefiran Polymers 0.000 claims description 2
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 2
- 244000285963 Kluyveromyces fragilis Species 0.000 claims 2
- 244000206911 Candida holmii Species 0.000 claims 1
- 235000002965 Candida holmii Nutrition 0.000 claims 1
- IJKRDVKGCQRKBI-UHFFFAOYSA-N Lactobacillinsaeure Natural products CCCCCCC1CC1CCCCCCCCCC(O)=O IJKRDVKGCQRKBI-UHFFFAOYSA-N 0.000 claims 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 claims 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 235000020247 cow milk Nutrition 0.000 claims 1
- IJKRDVKGCQRKBI-ZWKOTPCHSA-N lactobacillic acid Chemical compound CCCCCC[C@H]1C[C@H]1CCCCCCCCCC(O)=O IJKRDVKGCQRKBI-ZWKOTPCHSA-N 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 235000013305 food Nutrition 0.000 abstract description 13
- 230000009885 systemic effect Effects 0.000 abstract description 3
- 229940127554 medical product Drugs 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 55
- 210000003491 skin Anatomy 0.000 description 52
- 235000012054 meals Nutrition 0.000 description 46
- 235000013339 cereals Nutrition 0.000 description 40
- 239000000047 product Substances 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 17
- 230000037406 food intake Effects 0.000 description 14
- 230000006872 improvement Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 235000013336 milk Nutrition 0.000 description 12
- 239000008267 milk Substances 0.000 description 12
- 210000004080 milk Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000002087 whitening effect Effects 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000021466 carotenoid Nutrition 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 241000186000 Bifidobacterium Species 0.000 description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 5
- 235000005493 rutin Nutrition 0.000 description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 5
- 229960004555 rutoside Drugs 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 238000012353 t test Methods 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- -1 jojoba oil Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 244000253911 Saccharomyces fragilis Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 235000020195 rice milk Nutrition 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 229920002567 Chondroitin Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 235000020244 animal milk Nutrition 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 235000005471 carotenols Nutrition 0.000 description 2
- 150000001748 carotenols Chemical class 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 238000001629 sign test Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241001534878 Erisma Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000755689 Intruda Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to an internal use composition for skin care, and uses of the composition as foods and pharmaceuticals.
- Kefir grains are a traditional fermented milk starter (such as the Caucasus) called Kefir.
- Patent Document 1 describes a cosmetic material having a skin whitening effect and an active oxygen scavenging effect, characterized in that it contains a cell extract of Lactobacillus genus Lactobacillus separated from kefir grains.
- Patent Document 2 discloses a fermentation broth prepared by inoculating Kefir grain strength, isolated Saccharomyces yeasts, culturing, and removing the yeast from the obtained culture broth.
- a safe cosmetic that has a skin whitening effect and is characterized by being formulated is described.
- Patent Document 3 describes a cosmetic for removing stains, buckwheat, moles and the like, characterized by blending a culture supernatant of kefir grains.
- Patent Document 1 JP-A-5-163134
- Patent Document 2 Japanese Patent Laid-Open No. 7-10734
- Patent Document 3 International Publication No. 01/019324 Pamphlet
- An object of the present invention is to provide a skin care means that can exert a systemic effect with no side effects even if it is regularly used by internal use, and that the effect is not reduced by perspiration or friction.
- the present invention relates to a composition for internal use for skin care containing Kefia fermented milk, and the use of this composition as a food and a medicine.
- the present invention also relates to a method of using the above-mentioned internal use composition for skin care. Furthermore, the present invention also relates to a method of using kefir fermented milk for producing an internal composition for skin care.
- an internal composition for skin care can be obtained.
- the fermented milk of kefir bacterium used in the present invention is a naturally derived product and is essentially edible, so it can be safely used as an internal medicine.
- the composition of the present invention can be used internally, a systemic effect can be expected, and the effect is not reduced by perspiration or friction.
- Kefia fermented milk used in the present invention refers to kefir and kefir-like fermented milk, and mixtures thereof.
- the kefir fermented milk used in the present invention is preferably kefir.
- the kefir used in the present invention refers to fermented milk obtained using kefir grains as seed bacteria.
- the kefir grains refer to a bacterial mass in which lactic acid bacteria and yeast coexist, that is, a natural immobilized microorganism symbiosis.
- Symbiosis is a phenomenon in which different organisms live in a positional and geographically steady relationship.
- the kefir grains used in the present invention are not particularly limited as long as they are used as inoculum of kefir.
- the inoculum of kefir that is widely eaten and consumed in the Caucasus region May be used.
- the kefir grains used in the present invention are symbiotic with lactic acid bacteria and yeast, and are different from those in which lactic acid bacteria and yeast are simply mixed.
- the kefir grains of the present invention include, for example, viscous polysaccharides (such as kefiran) in addition to bacteria, 50-55 of the total amount of kefir grains. /. May be included.
- viscous polysaccharides such as kefiran
- symbiotic bacteria in kefir grains are more vigorous and effective than the same type of bacteria that exist alone or in a mixture, such as by the action of substances such as bacteriocin secreted by each other. Excellent in component secretion.
- Bacteria symbiotic in the kefir grains of the present invention and those in which lactic acid bacteria and yeast are mixed can be distinguished by the following method.
- the bacteria that are symbiotic in the kefir grains of the present invention are simply mixed with lactic acid bacteria and yeast. Excellent antibacterial activity against coliforms.
- the above disc method is described, for example, in McGroarty, J.A. and Reid, G. 1988. Detection of a lactobacillus substance that inhibits Escherichia coli. Can. J. Microbiol, 34: 974-978.
- the kefir grains used in the present invention can be obtained from, for example, License Intruda ( Russian). In the present invention, for example, it is preferable to use kefir grains activated according to the method described in JP-A-62-283842.
- a product obtained by separation from kefir by a conventional method for example, culture powder can be used as kefir grains.
- culture powders are commercially available from Wisby (Germany), Ryosan (Canada) and Roselle (Strength Nada).
- kefir of the present invention those marketed by Nippon Kefir Company can be used.
- kefir can also be produced according to conventional methods, for example, methods described in JP-A Nos. 62-83842 and 2000-166467.
- methods described in JP-A Nos. 62-83842 and 2000-166467 for example, fermenting animal milk, soy milk or rice milk, or a mixture thereof, or skim milk, processed milk, prepared milk or dairy products, etc. at 25 ° C for 24 hours using kefir grains as inoculum You can get more power S.
- animal milk for example, milk such as cow, buffalo, horse, sheep or goat, as soy milk, for example fermented products or emulsions such as soybean
- rice milk for example, white rice Milk or brown rice milk
- white rice Milk or brown rice milk can be used.
- kefir fermented with soy milk by fermentation with a fermentation aid for example, an enzymatic degradation product of casein, and a mineral derived from milk
- a fermentation aid for example, an enzymatic degradation product of casein, and a mineral derived from milk
- fermented products obtained by the method shown below are also preferred as kefir of the present invention.
- Step 1) Inoculate 0.15 15 g (preferably 0.3 10 g, more preferably 0.5-4. 5 g) of kefir grains against lOOg of sterilized soymilk composition;
- Step 2) 8-72 hours at 5-30 ° C (preferably 15-25 ° C, more preferably 18 ° C-23 ° C), and / or f acidity SO. 55-1.50 (preferably Fermentation until f 0.60-1.20, more preferably f 0.665-0.90).
- Step b) Inoculum is prepared by culturing at 5-30 ° C (preferably 15-25 ° C, more preferably 18 ° C-23 ° C).
- lactic acidity refers to lactic acid acidity unless otherwise specified. This lactic acid acidity is obtained by performing neutralization titration with 1 / 10N NaOH using 1% phenolphthalein solution as an indicator, and converting the acid contained in food from the required 1 / 10N NaOH into the amount of lactic acid. be able to.
- the soymilk composition used in the above step 1 contains a fermentation aid in addition to soymilk or water soymilk. With this aid, the composition of the soy milk composition should be close to that of milk.
- auxiliary used in the present invention commercially available fermentation auxiliary, for example, those used in the production of yognoreto or cheese can be used alone or in combination.
- P as inorganic phosphorus
- Fe is 0.001 or more, more Preferably it is 1 or less
- Na is 0.006 or more, more preferably 0.6 or less
- K is 0.001 or more, more preferably 1 or less
- Mg is 0.007 or more. More preferably, it is 0.07 or less
- C1 is 0.008 or more, more preferably 0.8 or less
- lactose is 0.01 or more, more preferably 50 or less.
- Auxiliaries that can be used in the present invention may include whey (eg, whey produced during cheese manufacture) concentrates.
- Table 1 shows examples of fermentation aids.
- the soy milk formulation may optionally comprise an animal protein, preferably peptone; a protein hydrolyzed small molecule mixture.
- animal protein and peptone commercially available products can be used.
- the kefir-like fermented milk used in the present invention uses a mixture of lactic acid bacteria and yeast as seed bacteria instead of kefir grains, and can be produced by the same method as the above kefir. S can.
- the lactic acid bacteria and yeast can be obtained by isolation and culture from kefir grains, or those not derived from kefir grains can be used.
- the kefir fermented milk of the present invention may be a mixture of the above kefir grains and lactic acid bacteria, yeasts or acetic acid bacteria not derived from the kefir grains.
- the kefir fermented milk may be in a liquid form with no particular limitation on the form, but may be in the form of a solid, particularly a powder.
- the conventional free The product obtained by the freeze drying method is advantageous because the composition of the fermented milk is maintained and concentrated.
- Examples of the lactic acid bacteria include Lactobacillus and lactic acid cocci.
- Lactobacillus casei Lactobacillus kefiranofaciens; Lactobacillus casei;
- Lactobacillus kefiri; 7 can be used for Lactobacillus brevis.
- Lactococcus lactis As lactic acid cocci, for example, Lactococcus lactis; Enterococcus faecalis; streptococcus lactis; Streptococcus cremons; Streptococcus diacetylactis;
- yeast examples include lactose fermentable yeast and lactose non-fermentable yeast.
- lactose-fermenting deciduous yeasts examples include Kluyveromyces marxianus, particularly Kluyveromyces marxianus var. Marxianus or i ⁇ Kiuyveromyces marxianus var. Lactis; Candita keiyr; or Brettanomyces anomalus.
- lactose non-fermentable yeast for example, Saccharomyces unisporous
- the inoculum used for producing the kefir grains or kefir-like fermented milk used in the present invention may contain any combination of the above-mentioned bacteria, but preferably 10-15 species of lactic acid bacteria and yeast 6 — 10 species, more preferably 7 lactobacilli and 10 yeasts.
- the inoculum when producing the kefir grains or kefir-like fermented milk of the present invention may further contain 7 types of lactic acid cocci.
- the inoculum used in producing the kefir grains or kefir-like fermented milk of the present invention is preferably a four-fold weight of Lactobacillus kefiranofaciens, Lactobacillus kefin, Lactobacillus brevis and Leuconostoc mesenteroides as the Lactobacillus Candita kefyr as the yeast. Contains 1 or more, especially 3 of ⁇ Candita holmii or Saccharomyces unisporaqs.
- the inoculum used in the production of the kefir grains or kefir-like fermented milk of the present invention is optionally.
- acetic acid bacteria may be included.
- the above-mentioned bacteria contained in the kefir fermented milk used in the present invention may be live or dead. Further, the fermented milk of kefir fungus of the present invention may contain both live and dead bacteria.
- the composition of the present invention comprises ingredients that can be used for skin care, such as vegetable oils, carotenoids, antioxidants, vitamins, amino acids, mineralolates, collagen, chondroitin, chondroitin sulfate, elastin, hyanorenoic acid, gnorecosamine, oligosaccharide, May contain phospholipids such as icosapentaenoic acid, docosahexaenoic acid, linolenoreic acid, linolenic acid, arbutin, kojic acid, placenta, lucinole, ellagic acid, vegetable ceramide and squalene, and anti-inflammatory agents. Les. Preferable are collagen, chondroitin, hyanorelonic acid, placenta, and phospholipids such as plant ceramide and squalene.
- These components may be synthetic products, natural products, or natural products, and may be crude extracts or purified products.
- the above-described components can be used alone or in combination of two or more.
- the vegetable oil used in the present invention can be obtained from plant seeds by pressing or the like.
- Preferred are safflower oil, wheat germ oil and soybean oil.
- the extraction method and the purification method of the vegetable oil are not particularly limited.
- the vegetable oil of the present invention may be a crude extract or a purified product.
- the above vegetable oils may be used alone or in combination of two or more.
- carotenoids examples include carotenoid hydrocarbons and carotenol (xanthophyll).
- the carotenoid hydrocarbon is, for example, j3-force rotin and lycopene (lycopene), and preferably / 3-carotene.
- the above carotenol includes, for example, rutin, zeaxanthin, cryptoxanthin, canthaxanthin, capsanthin hydradex.
- rutin and zeaxanthin particularly preferably rutin.
- These carotenoids are preferably naturally derived products.
- a marigold extract containing rutin, particularly an extract from a petal of maricold is preferred.
- these carotenoids can be used singly or in combination of two or more.
- / 3-force rotin and rutin can be used in combination.
- antioxidants examples include vitamin C, vitamin E, anthocyanin and polyphenol. Vitamin C and vitamin E are preferred.
- antioxidants are preferably natural products.
- soybean extract containing vitamin E particularly soybean oil containing vitamin E is preferred.
- antioxidants can be used alone or in combination of two or more.
- vitamin A oil examples include vitamin A oil, vitamin Bl, vitamin B2, vitamin B6, vitamin B12, nicotinic acid amide, calcium pantothenate, vitamin C, vitamin D2, vitamin E, and vitamin K.
- Vitamin B2 and the like are preferable.
- the composition of the present invention may contain these vitamins alone or in combination of two or more.
- Examples of the mineral include copper, zinc, selenium, calcium, manganese, potassium, and iron.
- the composition of the present invention may contain these minerals alone or in combination of two or more.
- amino acids examples include tryptophan, threonine, and methionine.
- the composition of the present invention may contain these amino acids alone or in combination of two or more.
- composition of the present invention contains excipients, sweeteners, acidulants, thickeners, flavors, pigments, emulsifiers, and other materials commonly used in foods. It may be included.
- composition of the present invention can be used for skin care for skin care.
- it can be used for whitening and skin beautification.
- the composition of the present invention can be used, for example, for the prevention / treatment of sunburn prevention 'improvement or stain' buckwheat.
- “Beautiful skin” refers to, for example, use for giving the skin firmness, luster, softness, smoothness, and transparency, making the texture more vigorous, and adjusting. Therefore, the composition of the present invention can prevent wrinkles and sagging caused by, for example, aging, exposure to ultraviolet rays, changes in hormone balance, and active oxygen injury, etc. for improving, improving skin elasticity, moisturizing skin, acne or pimples ⁇ Can be used for improvement or for rough skin prevention
- the fact that it is used for the above-mentioned skin care uses is indicated on the body, packaging, instructions or promotional material of the internal use composition of the present invention, so that the conventional kefir bacteria It may be distinguished from fermented milk.
- the main body means a container directly containing the internal composition of the present invention
- the packaging means a paper or a box surrounding the container
- the instruction is a document explaining the internal composition of the present invention.
- the promotional material is a document used to promote the sales of the internal use composition of the present invention.
- the composition according to the present invention is used as a food, particularly as a health food, a functional food, a health supplement, a food for specified health use, a beauty food, and a nutritional supplement (sublimation) for the purpose of skin care or the like.
- a food particularly as a health food, a functional food, a health supplement, a food for specified health use, a beauty food, and a nutritional supplement (sublimation) for the purpose of skin care or the like.
- These foods may be in the form of, for example, drinking water such as tea and juice; ice cream, jelly, candy, chocolate and chewing gum. It may also be in the form of a liquid, powder, granule, capsule or tablet.
- composition according to the present invention can be used as a medicine, for example, for the prevention or treatment of freckles.
- These pharmaceuticals are administered orally, for example, in the form of tablets, coated tablets, dragees, hard or soft gelatin capsules, solutions, emulsions or suspensions.
- the intake of the composition according to the present invention is not particularly limited, but can be appropriately selected according to the dosage form and the age, weight and symptoms of the user or patient.
- an oral intake of kefir 0.3 g 9 g, preferably 26 g, more preferably 4 g to 6 g as an active ingredient amount per day for an adult is desirable.
- the intake period depends on the age and symptoms of the user or patient. It can be arbitrarily determined depending on the situation.
- Kefir grains obtained from Nippon Kefia containing Lactobacillus kenranomciens, Lactobacillus kefiri, Lactooacillus brevis, Kluyveromyces marxianus, Candita kefyr, Candita holmii and Saccharomyces unisporaqs were used.
- This disc was placed approximately in the center on the BYE plate medium. Next, this BYE plate medium was incubated at 4 ° C. for 3 hours, so that the bacterial culture solution soaked in the disk was diffused into the medium. Subsequently, after incubation at 37 ° C for 18 hours, the inhibition zone around the disk was examined.
- the prepared milk prepared by adding skim milk powder to milk was sterilized, then cooled, inoculated with the above kefir grains as inoculum, and fermented at 25 ° C for 24 hours to obtain fermented milk.
- This fermented milk was freeze-dried to obtain Kefir MSL as a powder.
- Kefir MSD was obtained as a powder in the same manner as the above kefir MSL, except that it was sterilized after lyophilization.
- Kefir MSL and Kefir MSD have a total solid content of 96-98%, protein Quality 22—25%, Moon quality 9. 0—11%, Sugar 54—55%, Ash content 5.2—5.8%, Energy 3
- Kefir MSL 90—417 kcal.
- the number of viable bacteria contained in Kefir MSL was 10 8 / g or more for lactic acid bacteria and 10 5 / g or more for yeast.
- soy milk 1013 g of soy milk (manufactured by Marusan) was sterilized at 80 ° C. This was inoculated with 50 g of kefir grains (obtained from Nippon Kefia) and cultured at 20 ° C. A soft card was formed 19 hours after inoculation, but the acidity was 0.40. Twenty-four hours after inoculation, the acidity was 0.50.
- the milk sterilized at 90 ° C was inoculated with 1.5% (by weight) of Caucasian kefir grains (obtained from Nippon Kefia) and cultured at 20 ° C for 20 hours to obtain an inoculum.
- Soy milk (manufactured by Nippon Beans) 900g was sterilized at 70 ° C and cooled (10 ° C).
- the inoculum prepared above was inoculated with 1.5% (weight ratio) and cultured at 20 ° C.
- Each of 160 g of milk sterilized at 90 ° C was inoculated with 2.5 g of kefir grains (obtained from Nippon Kefia) and cultured at 20 ° C for 20 hours. The card was well formed. Cooled 24 hours after inoculation.
- curds were formed in each case, but they were softer than the soymilk fermented product preparation example 3.
- the electrode was cooled after 24 hours.
- Each acidity is shown in Table 5.
- Formulations containing the soymilk in Table 6 (manufactured by Marusan; unprepared, BX10.6) were sterilized by conventional methods.
- Soy milk manufactured by Nippon Beans Co., Ltd .; BX12. 8 20 kg of water was added to 150 kg (BX11.1). Sterilized at 80 ° C for 5 minutes.
- auxiliaries in Table 1 (1.9 kg (final concentration 1.1%)) and peptone 0.36 kg (final concentration 0.2%) dissolved in 10 kg of water were sterilized at 80 ° C for 5 minutes.
- the acidity was 0.60 19 hours after the inoculation, and the acidity was 0.72 20 hours after the inoculation.
- the obtained fermentation product was sterilized at 85 ° C for 5 minutes.
- the fermented product was lyophilized by a conventional method to obtain a light yellow powder.
- the powder did not feel the unique smell of soy milk.
- Test meals 1 and 2 were prepared to have the composition shown in Table 7. [0066] Table 7
- the subjects were 10 healthy women aged 31-40 years old who had dry and rough skin or acne skin as subjective symptoms. During the study period, subjects were not allowed to use any drug, topical medicine, or health food that had an effect on the skin other than test meals 1 and 2.
- test meal 1 or test meal 2 Subjects ingested either test meal 1 or test meal 2 at a dose of 2 g, 3 times a day, with water for 28 days.
- ultraviolet light with the minimum amount of erythema was irradiated on the inner side of one of the upper arms of the test subject, and melanin, erythma and L values were measured 14 days and 28 days later using a meggeter meter and color difference meter. Subsequently, ingestion of the test meal was started and continued for 28 days. At the beginning of the test meal intake, the inside of the upper arm, which was different from the previous irradiation of ultraviolet rays, was irradiated with the same amount of ultraviolet rays as the previous minimum erythema amount. Value, erythema value and L value were measured.
- the eyelids were taken in replicas, and then the test meals were started and taken continuously for 28 days. On the 28th day, the eyes were taken again in replicas.
- This Parallel light was irradiated to the Prica from a certain direction (30 °), and the resulting shadow was image-processed. From this, the shadow area and its length were calculated.
- the standard scale force also calculated the shadow area and its length, and corrected the numerical value of the eye corner replica. From these values, the sea area ratio, the maximum sea average depth and the maximum sea maximum depth were calculated.
- the viscoelasticity of the skin was measured by the change in the skin sucked into the probe by applying a constant negative pressure to the skin surface inside the forearm with the probe of the cutometer. Subsequently, the ingestion of the test meal was started and continued for 28 days. On the 28th day, the viscoelasticity of the skin was measured again as described above.
- the probe of the Corneometer Before the test meal is ingested, the probe of the Corneometer is brought into close contact with the skin surface on the inner side of the forearm, so that the microprocessor in the device reads the switch information in the probe and the measurement time during which electricity flows and registers them.
- the keratin moisture content was measured by evaluating with calibration data. Subsequently, the intake of the test meal was started, and the intake was continued for 28 days. On the 28th day, the keratin water content was measured again as described above.
- the number of bifidobacteria in the stool was measured according to a conventional method before and after the intake of the test food (on the 28th day after ingestion).
- a questionnaire survey on lifestyle was conducted at the start of the study, followed by a questionnaire survey on the skin just before the start of taking the test meal, on the 14th day and 28th day after the intake.
- Subjects were asked to fill out a diary of their daily diet, physical condition and test meal intake during the test meal intake period.
- melanin INDEX value mean value ⁇ standard deviation of 10 subjects
- the 14th day was before the test meal intake. In this period, it was 101.74 ⁇ 1.33%, and during the period of ingestion of the test meal, it was 99.74 ⁇ 1.40%, which was reduced by 2.0% by taking the test meal.
- 101.24 ⁇ 1.02% was shown in the period before taking the test meal, 99.21 ⁇ 1.02% in the period before taking the test meal, and 2.03% by taking the test meal. A significant difference was observed (p 0.01, t test).
- the INDEX value (average soil standard deviation of 10 subjects) was 102.39 ⁇ 1.52% for the period before taking the test meal, and for the period while taking the test meal. ⁇ indicates 101. 50 ⁇ 1. 52 0/0 , 0. 89 0/0 decreased by the intake of the test meal. On the 28th day, it shows 102. 64 ⁇ 3.02% in the period before taking the test meal, and 101.5 1 ⁇ 1.89% in the period before taking the test meal. % Reduction was observed.
- the measured value represents the average soil standard deviation of 10 subjects.
- the wrinkle area rate was reduced by 3.83% in 3 subjects out of 10 subjects by the intake of the test meal, and decreased by 7.83% on average.
- Isobe In 7 of the 10 subjects, improvement was observed before and after taking the test meal.
- the stratum corneum water content (mean soil standard deviation) of 10 cases was 51.83 ⁇ 63.87 S before ingestion, while the post-ingestion force was 63.87 ⁇ 10.68 / is, an improvement of 12.04 / is Increased significantly (p ⁇ 0.05, t test).
- the skin condition was evaluated for moisture, agitation, elasticity, texture, transparency, and wrinkles.
- the case where each state could not be recognized was evaluated with a score between 1 and 5 points, and the case where each state was recognized with a score between 1 and 5 points, respectively.
- Table 9 shows the average values of 10 subjects. In terms of the average of the 10 cases, the scores on the 14th and 28th days after ingestion increased in all conditions compared to before the intake of the test meal.
- test meal 1 In the intestinal bacteria, an increase in bifidobacteria called good bacteria was observed. In test meal 1, an excellent whitening effect and wrinkle improvement effect were observed. On the other hand, the test food 2 had an excellent moisturizing effect.
- the fermented soymilk product prepared above showed a whitening effect, an improvement effect on the viscoelasticity of the skin, an improvement effect on the moisturizing function (horny layer moisture content), and an increase effect of bifidobacteria.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005513347A JP5048246B2 (ja) | 2003-08-26 | 2004-08-25 | スキンケア用の内服組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003301066 | 2003-08-26 | ||
JP2003-301066 | 2003-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005018653A1 true WO2005018653A1 (ja) | 2005-03-03 |
Family
ID=34213869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/012183 WO2005018653A1 (ja) | 2003-08-26 | 2004-08-25 | スキンケア用の内服組成物 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5048246B2 (ja) |
CN (1) | CN100534446C (ja) |
WO (1) | WO2005018653A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007000750A (ja) * | 2005-06-23 | 2007-01-11 | Spring:Kk | 活性酸素消去剤、及び活性酸素消去剤の製造方法 |
JP2008179601A (ja) * | 2006-12-28 | 2008-08-07 | Suntory Ltd | ラクトバチルス属菌を含む美容組成物 |
WO2010021117A1 (ja) * | 2008-08-18 | 2010-02-25 | 日本ケフィア株式会社 | 乳清ケフィアを有効成分として含んでなる、内服用美肌剤 |
JP4795426B2 (ja) * | 2005-04-01 | 2011-10-19 | ハムレット プロテイン アクティーゼルスカブ | 発酵させたタンパク質生成物 |
WO2012002322A1 (ja) * | 2010-06-28 | 2012-01-05 | 株式会社ヤクルト本社 | 経口用皮膚性状改善剤 |
CN109965269A (zh) * | 2017-12-28 | 2019-07-05 | 荣宝高科技(武汉)有限公司 | 食品组合物及其应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102056489B (zh) * | 2008-06-10 | 2012-08-01 | 株式会社妃丝 | 新型发酵乳及其应用 |
CN103025338B (zh) * | 2010-05-21 | 2015-01-28 | 株式会社明治 | 用于改善皮肤状态的组合物 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6283842A (ja) * | 1985-10-08 | 1987-04-17 | Sennosuke Tokumaru | 凍結乾燥ヨ−グルトとその製造方法 |
JPH0838046A (ja) * | 1994-07-28 | 1996-02-13 | Nakagaki Gijiyutsushi Jimusho:Kk | 醗酵乳用種菌及びそれにより調製された醗酵乳 |
JPH0937711A (ja) * | 1995-07-28 | 1997-02-10 | Sennosuke Tokumaru | 健康食品 |
JPH09191852A (ja) * | 1996-01-19 | 1997-07-29 | Sennosuke Tokumaru | 健康食品 |
JP2000032909A (ja) * | 1998-07-21 | 2000-02-02 | Bio Health:Kk | 微生物由来の腸内環境改善による消化吸収向上食品 |
JP2000166467A (ja) * | 1998-12-10 | 2000-06-20 | Nippon Kefia Kk | 乳発酵産物及びハーブ類を含有してなる健康食品 |
JP2002540807A (ja) * | 1999-04-13 | 2002-12-03 | シグマ−タウ・ヘルスサイエンス・ソシエタ・ペル・アチオニ | 骨粗鬆症の予防のための発酵乳由来の栄養補助食品 |
JP2003081854A (ja) * | 2001-07-06 | 2003-03-19 | Fuji Oil Co Ltd | 便通改善用組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2622797B1 (fr) * | 1987-11-05 | 1991-02-01 | Oreal | Composition cosmetique a base de yaourt ou de kefir |
JP2911199B2 (ja) * | 1990-09-14 | 1999-06-23 | 三省製薬株式会社 | 外用剤 |
JPH05163134A (ja) * | 1991-12-18 | 1993-06-29 | Dowa Mining Co Ltd | 化粧料 |
JPH0710734A (ja) * | 1993-06-21 | 1995-01-13 | Dowa Mining Co Ltd | 化粧料 |
JP3533427B2 (ja) * | 1999-09-14 | 2004-05-31 | 株式会社応微研 | 化粧料 |
JP3619185B2 (ja) * | 2001-06-22 | 2005-02-09 | 株式会社ナリス化粧品 | 化粧料 |
-
2004
- 2004-08-25 JP JP2005513347A patent/JP5048246B2/ja active Active
- 2004-08-25 WO PCT/JP2004/012183 patent/WO2005018653A1/ja active Application Filing
- 2004-08-25 CN CNB200480024427XA patent/CN100534446C/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6283842A (ja) * | 1985-10-08 | 1987-04-17 | Sennosuke Tokumaru | 凍結乾燥ヨ−グルトとその製造方法 |
JPH0838046A (ja) * | 1994-07-28 | 1996-02-13 | Nakagaki Gijiyutsushi Jimusho:Kk | 醗酵乳用種菌及びそれにより調製された醗酵乳 |
JPH0937711A (ja) * | 1995-07-28 | 1997-02-10 | Sennosuke Tokumaru | 健康食品 |
JPH09191852A (ja) * | 1996-01-19 | 1997-07-29 | Sennosuke Tokumaru | 健康食品 |
JP2000032909A (ja) * | 1998-07-21 | 2000-02-02 | Bio Health:Kk | 微生物由来の腸内環境改善による消化吸収向上食品 |
JP2000166467A (ja) * | 1998-12-10 | 2000-06-20 | Nippon Kefia Kk | 乳発酵産物及びハーブ類を含有してなる健康食品 |
JP2002540807A (ja) * | 1999-04-13 | 2002-12-03 | シグマ−タウ・ヘルスサイエンス・ソシエタ・ペル・アチオニ | 骨粗鬆症の予防のための発酵乳由来の栄養補助食品 |
JP2003081854A (ja) * | 2001-07-06 | 2003-03-19 | Fuji Oil Co Ltd | 便通改善用組成物 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4795426B2 (ja) * | 2005-04-01 | 2011-10-19 | ハムレット プロテイン アクティーゼルスカブ | 発酵させたタンパク質生成物 |
JP2007000750A (ja) * | 2005-06-23 | 2007-01-11 | Spring:Kk | 活性酸素消去剤、及び活性酸素消去剤の製造方法 |
JP2008179601A (ja) * | 2006-12-28 | 2008-08-07 | Suntory Ltd | ラクトバチルス属菌を含む美容組成物 |
WO2010021117A1 (ja) * | 2008-08-18 | 2010-02-25 | 日本ケフィア株式会社 | 乳清ケフィアを有効成分として含んでなる、内服用美肌剤 |
JPWO2010021117A1 (ja) * | 2008-08-18 | 2012-01-26 | 日本ケフィア株式会社 | 乳清ケフィアを有効成分として含んでなる、内服用美肌剤 |
WO2012002322A1 (ja) * | 2010-06-28 | 2012-01-05 | 株式会社ヤクルト本社 | 経口用皮膚性状改善剤 |
US9439933B2 (en) | 2010-06-28 | 2016-09-13 | Kabushiki Kaisha Yakult Honsha | Skin properties improving agent for oral administration |
CN109965269A (zh) * | 2017-12-28 | 2019-07-05 | 荣宝高科技(武汉)有限公司 | 食品组合物及其应用 |
JP2019118281A (ja) * | 2017-12-28 | 2019-07-22 | ハイドロックス株式会社 | ケフィア粒構成菌産生物 |
Also Published As
Publication number | Publication date |
---|---|
CN1842340A (zh) | 2006-10-04 |
JPWO2005018653A1 (ja) | 2007-11-01 |
JP5048246B2 (ja) | 2012-10-17 |
CN100534446C (zh) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2697735C (en) | Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin | |
JP5954828B2 (ja) | 皮膚状態の改善用組成物 | |
KR101598039B1 (ko) | 피부 개선용 및/또는 치료용의 발효유와 그 제조 방법 | |
JP5791009B2 (ja) | 乳酸菌およびそれらを用いた飲食物又は化粧品 | |
JP5903380B2 (ja) | 経口用皮膚性状改善剤 | |
JP5635221B2 (ja) | 皮膚改善用及び/又は治療用の発酵乳とその製造方法 | |
KR102015180B1 (ko) | 유산균의 유크림 발효액을 유효성분으로 포함하는 화장료 조성물 | |
JP2013512946A (ja) | 皮膚の色つやの明るさを向上させる活性剤としてのプロバイオチックな微生物 | |
EP1609463A1 (fr) | Procédé et compositions utiles pour prévenir et/ou traiter les peaux sensibles et/ou sèches | |
JP2008179601A (ja) | ラクトバチルス属菌を含む美容組成物 | |
JP5270680B2 (ja) | 葉酸が混入された大豆発酵高分子物質及びこれを含む組成物 | |
CN113925923A (zh) | 一种抗痘美白的复合益生菌组合物及其制备方法 | |
KR102311097B1 (ko) | 초유의 호기성 발효산물 | |
JP5254682B2 (ja) | 経口摂取用皮膚性状改善剤 | |
JP5048246B2 (ja) | スキンケア用の内服組成物 | |
JP7383120B2 (ja) | 皮膚状態改善用組成物 | |
CN107106479B (zh) | 改善皮肤的脂肪团外观的组合物 | |
CN102742654B (zh) | 一种养颜美容益生菌羊奶片及其制备方法 | |
RU2178975C1 (ru) | Пищевой продукт с биологически активными добавками | |
WO2014049563A2 (en) | Use of a combination of taurine or a derivate thereof and a grape extract for improving the quality of the nails | |
KR20200057873A (ko) | 비피도박테리움 롱검 및 홉 추출물을 포함하는 항당뇨 또는 항아토피용 유제품 | |
TWI764356B (zh) | 含乳酸菌菌株或其發酵物的抗老化組合物及其用途 | |
TWI389698B (zh) | Fermented milk for use in skin improvement and / or treatment, and methods of making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480024427.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005513347 Country of ref document: JP |
|
122 | Ep: pct application non-entry in european phase |